Craig-Hallum Cuts MEDTOX Scientific (MTOX) to Sell
Tweet Send to a FriendGet Alerts MTOX Hot Sheet
Price: $27.00 --0%
Rating Summary:
0 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 23 | New: 23
Rating Summary:
0 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 23 | New: 23
Trade MTOX Now!
Craig-Hallum's Steven Crowley downgraded shares of MEDTOX Scientific (NASDAQ: MTOX) from Buy to Sell in a mid-day research note Monday. The downgrade follows earlier news LabCorp wants to buy the company.
Craig-Hallum's $22 price target was suspended. Shares of MEDTOX are up more than 35 percent to $35.42 at last check.
For an analyst ratings summary and ratings history on MEDTOX Scientific click here. For more ratings news on MEDTOX Scientific click here.
Shares of MEDTOX Scientific closed at $19.70 Friday, with a 52 week range of $11.64-$22.55.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Craig-Hallum's $22 price target was suspended. Shares of MEDTOX are up more than 35 percent to $35.42 at last check.
For an analyst ratings summary and ratings history on MEDTOX Scientific click here. For more ratings news on MEDTOX Scientific click here.
Shares of MEDTOX Scientific closed at $19.70 Friday, with a 52 week range of $11.64-$22.55.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
- Macquarie Downgrades Franklin Resources (BEN) to Neutral
- Urban Outfitters (URBN) Added to Best Ideas List at Janney Capital on Solid Q1 Results
Create E-mail Alert Related Categories
DowngradesLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

